Pfizer to Present 45 Oncology Abstracts at ESMO 2026
NEW YORK — September 28, 2026 Pfizer Inc. announced that it will present data from 45 company-sponsored, investigator-sponsored and...
Breast Cancer
Advertisement
Daiichi Sankyo and AstraZeneca Gain EU Backing for Enhertu
TOKYO — September 18, 2026 Daiichi Sankyo and AstraZeneca announced that the European Medicines Agency’s Committee for Medicinal Products...
Eli Lilly Wins FDA Approval for Inluriyo-Verzenio Combination
Indianapolis, Indiana, September 18, 2026 Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA)...
Ractigen Therapeutics Reports First-In-Human RNA Activation Data
Shanghai, China, September 16, 2026 Ractigen Therapeutics has announced that it will present first-in-human clinical data from its RNA...
Lumicell Expands LumiSystem Use in Breast Cancer Surgery Now
Waltham, Massachusetts, U.S., September 15, 2026 Lumicell, Inc. is expanding the commercial use of LumiSystem®, its fluorescence-guided imaging platform...
Advertisements
Prelude Therapeutics Gains FDA Clearance for PRT13722
WILMINGTON, Del. — September 10, 2026 Prelude Therapeutics Incorporated announced that the U.S. Food and Drug Administration (FDA) has...
Faeth Therapeutics Highlights PIKTOR Strategy Ahead of Phase 2 Data
AUSTIN, Texas — September 8, 2026 Faeth Therapeutics announced plans to host a virtual key opinion leader (KOL) event...
Alpha-9 Oncology Starts Phase 1 GRPR Radiotherapeutic Trial
Boston, Massachusetts, U.S., and Vancouver, British Columbia, Canada, September 8, 2026 Alpha-9 Oncology has announced the dosing of the...
Guardant Health Wins FDA Approval for Breast Cancer CDx
Palo Alto, California — September 4, 2026 Guardant Health announced that the U.S. Food and Drug Administration (FDA) has...
FDA Grants Accelerated Approval to Etcamah for Breast Cancer
Silver Spring, Maryland, USA, September 4, 2026 The U.S. Food and Drug Administration (FDA) has granted accelerated approval to...
Advertisement
